US Stock MarketDetailed Quotes

Tonix Pharmaceuticals (TNXP)

Watchlist
  • 13.980
  • -0.150-1.06%
Close Apr 17 16:00 ET
  • 13.950
  • -0.030-0.21%
Post 19:42 ET
198.59MMarket Cap-0.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tonix Pharmaceuticals (TNXP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
29.85%13.11M
108.75%5.39M
16.58%3.29M
-9.51%2M
-2.14%2.43M
29.94%10.09M
-31.68%2.58M
-29.26%2.82M
2.21M
2.48M
Operating revenue
29.85%13.11M
108.75%5.39M
16.58%3.29M
-9.51%2M
-2.14%2.43M
29.94%10.09M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
Cost of revenue
-14.49%6.64M
-10.57%1.06M
-12.09%1.37M
-2.82%3.27M
-43.19%943K
63.78%7.77M
-50.02%1.18M
-34.50%1.56M
3.37M
1.66M
Gross profit
177.67%6.47M
209.65%4.33M
51.78%1.92M
-9.92%-1.27M
80.78%1.49M
-23.06%2.33M
-0.92%1.4M
-21.55%1.27M
-1.16M
822K
Operating expense
66.70%129.16M
128.93%52.55M
124.43%34.01M
51.08%25.99M
-25.06%16.62M
-36.18%77.48M
-20.14%22.95M
-49.09%15.15M
-40.69%17.2M
-34.60%22.17M
Selling and administrative expenses
118.66%87.68M
128.96%35.68M
233.48%25.7M
115.97%16.2M
8.53%10.1M
15.39%40.1M
34.08%15.58M
-11.54%7.71M
6.77%7.5M
25.96%9.31M
-General and administrative expense
----
----
----
----
8.53%10.1M
----
----
----
6.77%7.5M
25.96%9.31M
Research and development costs
11.29%44.49M
104.18%16.94M
1.92%9.29M
11.57%10.82M
-42.19%7.44M
-53.87%39.97M
-51.54%8.3M
-56.70%9.11M
-55.87%9.7M
-51.48%12.86M
Other operating expenses
-16.11%-3.01M
92.33%-71K
41.13%-982K
---1.04M
---923K
---2.59M
---926K
---1.67M
----
----
Operating profit
-63.26%-122.69M
-123.69%-48.22M
-131.06%-32.09M
-48.48%-27.26M
29.13%-15.13M
36.52%-75.15M
21.13%-21.55M
50.67%-13.89M
36.70%-18.36M
37.02%-21.35M
Net non-operating interest income expense
434.74%4.06M
581.72%1.34M
534.98%1.23M
94,200.00%943K
-1.21M
-279K
-283K
1K
Non-operating interest income
18,745.45%4.15M
134,300.00%1.34M
6,738.89%1.23M
94,200.00%943K
----
--22K
--1K
--18K
--1K
----
Non-operating interest expense
-92.79%89K
--0
--0
----
----
--1.23M
--280K
--301K
----
----
Other net income (expense)
89.96%-5.39M
83.19%-39K
-2,527.27%-1.16M
96.76%-1.96M
-126.48%-1.7M
-3,216.96%-53.67M
-3,414.29%-232K
-125.58%-44K
-9,452.63%-60.42M
614.83%6.41M
Gain on sale of security
----
----
----
----
----
--6.15M
--0
----
---855K
--7.01M
Special income (charges)
96.45%-2.09M
--0
--0
--0
---2.09M
---58.96M
--43K
--0
---58.96M
--0
-Less:Impairment of capital assets
----
----
--0
----
----
----
----
--0
--58.96M
----
-Less:Other special charges
--2.09M
--0
----
----
--2.09M
----
----
----
----
----
-Write off
--0
----
----
--0
----
--58.96M
----
----
--58.96M
----
Other non- operating income (expenses)
-280.05%-3.3M
85.82%-39K
-2,527.27%-1.16M
-222.61%-1.96M
166.44%394K
-150.35%-867K
-4,028.57%-275K
-125.58%-44K
-193.81%-606K
-166.11%-593K
Income before tax
4.63%-124.02M
-112.60%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.24%-22.07M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Income tax
Net income
4.63%-124.02M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Net income continuous Operations
4.63%-124.02M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Minority interest income
Net income attributable to the parent company
4.63%-124.02M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.63%-124.02M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Basic earnings per share
91.75%-14.57
59.26%-3.98
84.17%-3.59
99.80%-3.86
99.47%-2.84
98.80%-176.6
99.35%-9.77
99.41%-22.68
60.98%-1.92K
94.78%-535.72
Diluted earnings per share
91.75%-14.57
59.26%-3.98
84.17%-3.59
99.80%-3.86
99.47%-2.84
98.80%-176.6
99.35%-9.77
99.41%-22.68
60.98%-1.92K
94.78%-535.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 29.85%13.11M108.75%5.39M16.58%3.29M-9.51%2M-2.14%2.43M29.94%10.09M-31.68%2.58M-29.26%2.82M2.21M2.48M
Operating revenue 29.85%13.11M108.75%5.39M16.58%3.29M-9.51%2M-2.14%2.43M29.94%10.09M-31.68%2.58M-29.26%2.82M--2.21M--2.48M
Cost of revenue -14.49%6.64M-10.57%1.06M-12.09%1.37M-2.82%3.27M-43.19%943K63.78%7.77M-50.02%1.18M-34.50%1.56M3.37M1.66M
Gross profit 177.67%6.47M209.65%4.33M51.78%1.92M-9.92%-1.27M80.78%1.49M-23.06%2.33M-0.92%1.4M-21.55%1.27M-1.16M822K
Operating expense 66.70%129.16M128.93%52.55M124.43%34.01M51.08%25.99M-25.06%16.62M-36.18%77.48M-20.14%22.95M-49.09%15.15M-40.69%17.2M-34.60%22.17M
Selling and administrative expenses 118.66%87.68M128.96%35.68M233.48%25.7M115.97%16.2M8.53%10.1M15.39%40.1M34.08%15.58M-11.54%7.71M6.77%7.5M25.96%9.31M
-General and administrative expense ----------------8.53%10.1M------------6.77%7.5M25.96%9.31M
Research and development costs 11.29%44.49M104.18%16.94M1.92%9.29M11.57%10.82M-42.19%7.44M-53.87%39.97M-51.54%8.3M-56.70%9.11M-55.87%9.7M-51.48%12.86M
Other operating expenses -16.11%-3.01M92.33%-71K41.13%-982K---1.04M---923K---2.59M---926K---1.67M--------
Operating profit -63.26%-122.69M-123.69%-48.22M-131.06%-32.09M-48.48%-27.26M29.13%-15.13M36.52%-75.15M21.13%-21.55M50.67%-13.89M36.70%-18.36M37.02%-21.35M
Net non-operating interest income expense 434.74%4.06M581.72%1.34M534.98%1.23M94,200.00%943K-1.21M-279K-283K1K
Non-operating interest income 18,745.45%4.15M134,300.00%1.34M6,738.89%1.23M94,200.00%943K------22K--1K--18K--1K----
Non-operating interest expense -92.79%89K--0--0----------1.23M--280K--301K--------
Other net income (expense) 89.96%-5.39M83.19%-39K-2,527.27%-1.16M96.76%-1.96M-126.48%-1.7M-3,216.96%-53.67M-3,414.29%-232K-125.58%-44K-9,452.63%-60.42M614.83%6.41M
Gain on sale of security ----------------------6.15M--0-------855K--7.01M
Special income (charges) 96.45%-2.09M--0--0--0---2.09M---58.96M--43K--0---58.96M--0
-Less:Impairment of capital assets ----------0------------------0--58.96M----
-Less:Other special charges --2.09M--0----------2.09M--------------------
-Write off --0----------0------58.96M----------58.96M----
Other non- operating income (expenses) -280.05%-3.3M85.82%-39K-2,527.27%-1.16M-222.61%-1.96M166.44%394K-150.35%-867K-4,028.57%-275K-125.58%-44K-193.81%-606K-166.11%-593K
Income before tax 4.63%-124.02M-112.60%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.24%-22.07M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Income tax
Net income 4.63%-124.02M-112.19%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.08%-22.11M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Net income continuous Operations 4.63%-124.02M-112.19%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.08%-22.11M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Minority interest income
Net income attributable to the parent company 4.63%-124.02M-112.19%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.08%-22.11M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.63%-124.02M-112.19%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.08%-22.11M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Basic earnings per share 91.75%-14.5759.26%-3.9884.17%-3.5999.80%-3.8699.47%-2.8498.80%-176.699.35%-9.7799.41%-22.6860.98%-1.92K94.78%-535.72
Diluted earnings per share 91.75%-14.5759.26%-3.9884.17%-3.5999.80%-3.8699.47%-2.8498.80%-176.699.35%-9.7799.41%-22.6860.98%-1.92K94.78%-535.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -